Vaccine adjuvants : (Record no. 389997)

MARC details
000 -LEADER
fixed length control field 06616cam a2200889Ia 4500
001 - CONTROL NUMBER
control field ocm55698114
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220204092147.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||uuuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 000428s2000 njua ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency YUS
Language of cataloging eng
Description conventions pn
Transcribing agency YUS
Modifying agency OCLCQ
-- N$T
-- YDXCP
-- CUV
-- CNTRU
-- GW5XE
-- IDEBK
-- OCLCQ
-- CUS
-- COO
-- OCLCQ
-- DAY
-- CSU
-- OCLCE
-- E7B
-- OCLCQ
-- OCLCO
-- OCLCQ
-- OCLCF
-- OCLCQ
-- EUW
-- EBLCP
-- OCLCQ
-- VT2
-- OCLCA
-- OTZ
-- STF
-- OCLCO
-- OCLCA
-- BUF
-- OCLCO
-- CASUM
-- MERER
-- OCLCQ
-- U3W
-- OCLCO
-- OCLCQ
-- AU@
-- OCLCO
-- OCLCA
-- OCLCQ
-- OCLCA
-- YOU
-- CANPU
-- OCLCQ
-- OCLCO
-- U3G
-- OCLCQ
-- HS0
-- GW5XE
-- OCLCQ
-- OCLCA
-- OCLCQ
-- OCLCA
-- INARC
-- LIP
-- UWK
-- LVT
-- OCLCQ
-- OCLCO
019 ## -
-- 170923324
-- 272404966
-- 320977931
-- 607601026
-- 609216039
-- 642460017
-- 771201878
-- 964890217
-- 967621868
-- 985040241
-- 993980458
-- 994752151
-- 1005745819
-- 1017903143
-- 1045327336
-- 1050735327
-- 1058391109
-- 1078042827
-- 1078825082
-- 1078865312
-- 1081207077
-- 1086814679
-- 1097346321
-- 1109038093
-- 1120894777
-- 1164904491
-- 1166255116
-- 1203632364
-- 1228577401
-- 1229573900
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781592590834
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1592590837
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 128082073X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781280820731
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9786610820733
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 6610820732
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780896037359
Qualifying information (alk. paper)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0896037355
Qualifying information (alk. paper)
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1385/1592590837.
Source of number or code doi
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000061122826
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15211906
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000069305056
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)55698114
Canceled/invalid control number (OCoLC)170923324
-- (OCoLC)272404966
-- (OCoLC)320977931
-- (OCoLC)607601026
-- (OCoLC)609216039
-- (OCoLC)642460017
-- (OCoLC)771201878
-- (OCoLC)964890217
-- (OCoLC)967621868
-- (OCoLC)985040241
-- (OCoLC)993980458
-- (OCoLC)994752151
-- (OCoLC)1005745819
-- (OCoLC)1017903143
-- (OCoLC)1045327336
-- (OCoLC)1050735327
-- (OCoLC)1058391109
-- (OCoLC)1078042827
-- (OCoLC)1078825082
-- (OCoLC)1078865312
-- (OCoLC)1081207077
-- (OCoLC)1086814679
-- (OCoLC)1097346321
-- (OCoLC)1109038093
-- (OCoLC)1120894777
-- (OCoLC)1164904491
-- (OCoLC)1166255116
-- (OCoLC)1203632364
-- (OCoLC)1228577401
-- (OCoLC)1229573900
042 ## - AUTHENTICATION CODE
Authentication code dlr
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR187.3
Item number .V33 2000
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QW 805
Item number V1154 2000
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCM.
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615/.372
Edition number 21
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Vaccine adjuvants :
Remainder of title preparation methods and research protocols /
Statement of responsibility, etc. edited by Derek T. O'Hagan.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Totowa, N.J. :
Name of publisher, distributor, etc. Humana Press,
Date of publication, distribution, etc. 2000.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (x, 342 pages) :
Other physical details illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Methods in molecular medicine ;
Volume/sequential designation v. 42
500 ## - GENERAL NOTE
General note Source of title; title from title screen.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note An overview of adjuvant use -- Harmful and beneficial activities of immunological adjuvants -- Freund's adjuvants -- Aluminum compounds as vaccine adjuvants -- Poly(lactice-coglycolide) microparticles as vaccine adjuvants -- Poly(methyl methacrylate) nanoparticles as vaccine adjuvants -- Aqueous formulation of adjuvant-active nonionic block copolymers -- Liposomes as immunological adjuvants and vaccine carriers -- Immunopotentiating reconstituted indluezna virosomes (IRIVs) -- Cochleates for induction of mucosal and systemic immune responses -- Virus-like particles as vaccine adjuvants -- The adjuvant MF59: a 10 year perspective -- Preparation of the syntex adjuvant formulation (SAF, SAF-m, SAF-1) -- The ISCOM technology -- QS-21 adjuvant -- MPL Immunostimulant: adjuvant formulations -- Cytokines as vaccine adjuvants: the use of interleukin-2 -- DNA as an adjuvant -- Transcutaneous immunizaation -- Mutant heat-lbile enterotoxins as adjuvants for CTL induction.
520 8# - SUMMARY, ETC.
Summary, etc. Annotation
Expansion of summary note Derek T. O'Hagan and a team of expert vaccinologists and pharmacologists thoroughly describe the preparation, characterization, and evaluation of a wide range of alternative vaccine adjuvants for use in preclinical studies. Each chapter carefully reviews a single adjuvant, and suggests why a specific adjuvant might be preferred for a given antigen, depending on what type of immune response is desired. Alternate adjuvant choices are also presented so that researchers can choose those most efficacious for their specific purpose. Comprehensive and highly practical, Vaccine Adjuvants: Preparation Methods and Research Protocols provides an effective guide to making and using vaccine adjuvants. By closely following directions from the book, today's researchers will be able optimally to induce specific immune responses against different types of antigens and to selectively manipulate the immune response in a favorable way.
506 ## - RESTRICTIONS ON ACCESS NOTE
Materials specified Use copy
Standardized terminology for access restriction Restrictions unspecified
Source of term star
Institution to which field applies MiAaHDL
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction [Place of publication not identified] :
Agency responsible for reproduction HathiTrust Digital Library,
Date of reproduction 2010.
Institution to which field applies MiAaHDL
538 ## - SYSTEM DETAILS NOTE
System details note Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
Uniform Resource Identifier <a href="http://purl.oclc.org/DLF/benchrepro0212">http://purl.oclc.org/DLF/benchrepro0212</a>
Institution to which field applies MiAaHDL
583 1# - ACTION NOTE
Action digitized
Time/date of action 2010
Jurisdiction HathiTrust Digital Library
Status committed to preserve
Source of term pda
Institution to which field applies MiAaHDL
546 ## - LANGUAGE NOTE
Language note English.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunological adjuvants.
9 (RLIN) 81582
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Vaccines.
9 (RLIN) 80811
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Vaccines.
9 (RLIN) 80811
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Adjuvants, Immunologic.
9 (RLIN) 956703
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunologic Factors.
9 (RLIN) 81584
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biological Products.
9 (RLIN) 81585
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Complex Mixtures.
9 (RLIN) 81586
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Physiological Effects of Drugs
9 (RLIN) 81587
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemicals and Drugs
9 (RLIN) 13222
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacologic Actions
9 (RLIN) 81588
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemical Actions and Uses
9 (RLIN) 80980
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 80262
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunological adjuvants.
Source of heading or term fast
Authority record control number (OCoLC)fst00967992
9 (RLIN) 81582
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Vaccines.
Source of heading or term fast
Authority record control number (OCoLC)fst01163573
9 (RLIN) 80811
650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Wetenschappelijke technieken.
Source of heading or term gtt
9 (RLIN) 956704
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 396
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Hagan, Derek T.
9 (RLIN) 81591
776 1# - ADDITIONAL PHYSICAL FORM ENTRY
Title Vaccine adjuvants
Record control number (DLC) 99088373
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in molecular medicine ;
Volume number/sequential designation v. 42.
9 (RLIN) 79864
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590837">https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590837</a>
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3036834
938 ## -
-- ebrary
-- EBRY
-- ebr10181298
938 ## -
-- EBSCOhost
-- EBSC
-- 201294
938 ## -
-- Internet Archive
-- INAR
-- vaccineadjuvants0000unse
938 ## -
-- YBP Library Services
-- YANK
-- 2625987
994 ## -
-- 92
-- ATIST
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
  Not Lost     EBook e-Library e-Library 26/06/2020   26/06/2020 26/06/2020 eBook

Powered by Koha